Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoping Yang

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Frontiers in Pharmacology|July 29, 2021
A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From ChinaChengxian Guo, Biwen Hu, Chengjun Guo, et al.
Frontiers in Pharmacology|November 12, 2019
Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy VolunteersChan Zou, Xiaocong Zuo, Jie Huang, et al.
Infectious Diseases and Therapy|November 2, 2021
Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I TrialYeping Luo, Wenjing Chen, Guoping Yang, et al.
Clinical Drug Investigation|June 16, 2023
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese VolunteersJunyu Xu, Nan Zhao, Jie Huang, et al.
Bioresource Technology|January 7, 2024
Simultaneous decontamination of phosphorus and bisphenol A from livestock wastewater with boehmite-modified carbon compositeYaru Peng, Xiu Zhang, Yuan Luo, et al.
European Journal of Pharmacology|May 2, 2025
Vitamin D deficiency enhances platelet activation and thrombosis by regulating VDR/Akt pathway based on platelet proteomicsShanshan Nie, Peng Huang, Huan Niu, et al.
Cancer Letters|February 13, 2018
Pharmacogenomics signature: A novel strategy on the individual differences in drug responseChengxian Guo, Xinjian Lin, Jiye Yin, et al.
Plos One|October 5, 2016
Readability and Content Assessment of Informed Consent Forms for Phase II-IV Clinical Trials in ChinaGaiyan Wen, Xinchun Liu, Lihua Huang, et al.
Frontiers in Pharmacology|May 25, 2026
A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjectsKunhong Deng, Jie Huang, Qian Wu, et al.
Clinical and Experimental Pharmacology & Physiology|April 23, 2019
Pharmacogenomics guidelines: Current status and future developmentChengxian Guo, Xiaoxue Xie, Jingao Li, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Frontiers in Pharmacology|July 29, 2021
A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From ChinaChengxian Guo, Biwen Hu, Chengjun Guo, et al.
Frontiers in Pharmacology|November 12, 2019
Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy VolunteersChan Zou, Xiaocong Zuo, Jie Huang, et al.
Infectious Diseases and Therapy|November 2, 2021
Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I TrialYeping Luo, Wenjing Chen, Guoping Yang, et al.
Clinical Drug Investigation|June 16, 2023
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese VolunteersJunyu Xu, Nan Zhao, Jie Huang, et al.
Bioresource Technology|January 7, 2024
Simultaneous decontamination of phosphorus and bisphenol A from livestock wastewater with boehmite-modified carbon compositeYaru Peng, Xiu Zhang, Yuan Luo, et al.
European Journal of Pharmacology|May 2, 2025
Vitamin D deficiency enhances platelet activation and thrombosis by regulating VDR/Akt pathway based on platelet proteomicsShanshan Nie, Peng Huang, Huan Niu, et al.
Cancer Letters|February 13, 2018
Pharmacogenomics signature: A novel strategy on the individual differences in drug responseChengxian Guo, Xinjian Lin, Jiye Yin, et al.
Plos One|October 5, 2016
Readability and Content Assessment of Informed Consent Forms for Phase II-IV Clinical Trials in ChinaGaiyan Wen, Xinchun Liu, Lihua Huang, et al.
Frontiers in Pharmacology|May 25, 2026
A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjectsKunhong Deng, Jie Huang, Qian Wu, et al.
Clinical and Experimental Pharmacology & Physiology|April 23, 2019
Pharmacogenomics guidelines: Current status and future developmentChengxian Guo, Xiaoxue Xie, Jingao Li, et al.
Pageof 23